IDL Diagnostics

The nomination committee, which is appointed in accordance with the principles adopted by the annual general meeting on May 15^th, 2025, consists of:

• Jerker Swanstein, (chairman of the nomination committee), representing Labbex Förvaltnings AB
• Jon Eiken, representing own shares
• Didrik Hamilton, representing own shares

Before the annual general meeting 2026, the nomination committee shall prepare a proposal for the election of the chairman and other members of the board of directors, the election of the chairman of the annual meeting, the election of auditors, the determination of fees, and matters pertaining to it.
 
For more information, please visit:
Nomination committee - IDL Diagnostics
 
Shareholders who wish to submit proposals to the nomination committee for the annual general meeting 2026 can e-mail info@idldiagnostics.com  (header ” IDL Diagnostics’ nomination committee”) or via letter to:

IDL Diagnostics AB
Att: Valberedning
P.O Box 11151
SE-161 11 Bromma
Sweden

The proposals should be submitted to the nomination committee before January 31st, 2026.